Compare QNRX & KNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNRX | KNRX |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 10.9M |
| IPO Year | 2023 | 2023 |
| Metric | QNRX | KNRX |
|---|---|---|
| Price | $6.88 | $0.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 944.9K | ★ 5.1M |
| Earning Date | 05-07-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.25 | $0.31 |
| 52 Week High | $41.80 | $3.45 |
| Indicator | QNRX | KNRX |
|---|---|---|
| Relative Strength Index (RSI) | 62.38 | 42.78 |
| Support Level | $4.23 | $0.33 |
| Resistance Level | $8.25 | $0.49 |
| Average True Range (ATR) | 0.61 | 0.04 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 57.06 | 0.73 |
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. The company's product, Knorex XPOSM, is a self-service, enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications.